Relaxin' the brain: a case for targeting the nucleus incertus network and relaxin-3/RXFP3 system in neuropsychiatric disorders.
Jigna Rajesh KumarRamamoorthy RajkumarTharindunee JayakodySubhi MarwariJia Mei HongSherie MaAndrew L GundlachMitchell K P LaiGavin S DawePublished in: British journal of pharmacology (2016)
This article is part of a themed section on Recent Progress in the Understanding of Relaxin Family Peptides and their Receptors. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.10/issuetoc.